drugset / Trial / NCT00130208

Effect of Sulodexide in Early Diabetic Nephropathy

NCT00130208

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to determine whether treatment with sulodexide is effective in reducing the level of urine albumin excretion in patients with early diabetic kidney disease expressed as microalbuminuria.

Timeline

Start
2005-08
Primary completion
2008-01
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Sulodexide Other / unclassified 100 mg Oral